Monitoring of Tissue and Plasma Imipenem Concentrations for the Treatment of Necrotizing Fasciitis With Carbapenem-Resistant Enterobacteriaceae—A Letter to the Editor-Reference-Cited by-同舟云学术

Monitoring of Tissue and Plasma Imipenem Concentrations for the Treatment of Necrotizing Fasciitis With Carbapenem-Resistant Enterobacteriaceae—A Letter to the Editor

Published:2024-03-26 Issue: Volume: Page:
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Dufraigne Antonin¹,Perinel-Ragey Sophie¹²,Guitton Jérôme³⁴,Cohen Sabine³,Thiery Guillaume¹⁵,Launay Manon¹⁶^ORCID

Affiliation:

1. Service de Médecine Intensive et Réanimation G, CHU de Saint-Etienne, Saint-Etienne, France;

2. SAINBIOSE U1059 Research Unit, Université Jean Monnet, INSERM, Saint-Etienne, France;

3. Laboratoire de Biochimie et Toxicologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France;

4. Laboratoire de Toxicologie, ISPB, Faculté de Pharmacie, Université Lyon 1, Université de Lyon, Lyon, France;

5. Research on Healthcare Performance RESHAPE, INSERM U1290, Université Claude Bernard Lyon, Villeurbanne, France; and

6. Centre régional de pharmacovigilance, CHU de Saint-Etienne, Saint Etienne, France.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference6 articles.

1. Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d'Anesthésie et Réanimation-SFAR);Guilhaumou;Crit Care,2019

2. Comparative review of the carbapenems;Zhanel;Drugs,2007

3. High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function;Lamoth;Antimicrob Agents Chemother,2010

4. Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients;Bai;Eur J Hosp Pharm,2023

5. Tissue distribution of imipenem in critically ill patients;Tegeder;Clin Pharmacol Ther,2002